Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Staphylococcal Infections | 2 | 2018 | 1099 | 0.72 | Why? |
| Haemophilus Infections | 1 | 2018 | 69 | 0.72 | Why? |
| Mass Drug Administration | 1 | 2019 | 143 | 0.72 | Why? |
| Epidemiologic Research Design | 1 | 2020 | 166 | 0.71 | Why? |
| Child Mortality | 1 | 2019 | 163 | 0.67 | Why? |
| Personhood | 1 | 2017 | 62 | 0.65 | Why? |
| Pneumonia, Pneumococcal | 1 | 2018 | 251 | 0.59 | Why? |
| Klebsiella Infections | 1 | 2018 | 466 | 0.51 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.51 | Why? |
| Picornaviridae Infections | 1 | 2018 | 544 | 0.50 | Why? |
| Confidentiality | 1 | 2017 | 581 | 0.46 | Why? |
| Mass Media | 1 | 2020 | 837 | 0.46 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.44 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.44 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 711 | 0.43 | Why? |
| Public Opinion | 1 | 2020 | 1165 | 0.42 | Why? |
| Intestinal Diseases | 1 | 2013 | 231 | 0.41 | Why? |
| Science | 1 | 2017 | 463 | 0.41 | Why? |
| Dengue | 2 | 2019 | 1565 | 0.38 | Why? |
| Seroepidemiologic Studies | 3 | 2020 | 10017 | 0.35 | Why? |
| Certification | 2 | 2020 | 261 | 0.34 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.33 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.33 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.32 | Why? |
| Family | 1 | 2020 | 2909 | 0.31 | Why? |
| Ventilators, Mechanical | 1 | 2017 | 2193 | 0.29 | Why? |
| Singapore | 6 | 2020 | 3641 | 0.28 | Why? |
| Azithromycin | 1 | 2019 | 3943 | 0.27 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.26 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.24 | Why? |
| Influenza, Human | 5 | 2020 | 10779 | 0.23 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.23 | Why? |
| Diarrhea | 1 | 2013 | 2743 | 0.22 | Why? |
| Hoarding | 1 | 2020 | 50 | 0.21 | Why? |
| Niger | 1 | 2019 | 116 | 0.20 | Why? |
| Haemophilus influenzae type b | 1 | 2018 | 30 | 0.19 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.19 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.19 | Why? |
| Malawi | 1 | 2019 | 287 | 0.18 | Why? |
| Tanzania | 1 | 2019 | 294 | 0.18 | Why? |
| Communicable Diseases | 1 | 2013 | 2148 | 0.18 | Why? |
| Anxiety | 2 | 2020 | 17311 | 0.17 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.17 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.16 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.16 | Why? |
| Severe Dengue | 1 | 2018 | 135 | 0.15 | Why? |
| Endemic Diseases | 1 | 2019 | 480 | 0.14 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.14 | Why? |
| Masks | 1 | 2017 | 8528 | 0.14 | Why? |
| Drug Resistance, Microbial | 1 | 2019 | 419 | 0.14 | Why? |
| Caliciviridae Infections | 1 | 2017 | 229 | 0.14 | Why? |
| Indonesia | 1 | 2018 | 1022 | 0.14 | Why? |
| Self Efficacy | 1 | 2020 | 717 | 0.13 | Why? |
| Thailand | 1 | 2018 | 1155 | 0.13 | Why? |
| Norovirus | 1 | 2017 | 294 | 0.13 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.13 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.12 | Why? |
| Klebsiella pneumoniae | 1 | 2018 | 658 | 0.12 | Why? |
| Infant | 5 | 2019 | 30274 | 0.12 | Why? |
| Rhinovirus | 1 | 2018 | 979 | 0.12 | Why? |
| Influenza Vaccines | 2 | 2019 | 2941 | 0.12 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.11 | Why? |
| Child, Preschool | 5 | 2019 | 36283 | 0.11 | Why? |
| Nose | 1 | 2017 | 1093 | 0.11 | Why? |
| Attitude | 1 | 2020 | 1481 | 0.11 | Why? |
| Metformin | 1 | 2018 | 640 | 0.11 | Why? |
| Humans | 22 | 2021 | 930598 | 0.10 | Why? |
| Orthomyxoviridae | 1 | 2018 | 1168 | 0.10 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.10 | Why? |
| Vaccination Coverage | 1 | 2019 | 1249 | 0.10 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.10 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.09 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.09 | Why? |
| Qualitative Research | 1 | 2020 | 4337 | 0.09 | Why? |
| Community-Acquired Infections | 2 | 2017 | 2328 | 0.09 | Why? |
| Urban Population | 1 | 2018 | 2000 | 0.09 | Why? |
| Military Personnel | 1 | 2018 | 1097 | 0.09 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.08 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.08 | Why? |
| Family Characteristics | 1 | 2017 | 2551 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Adult | 9 | 2021 | 244371 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Male | 10 | 2021 | 367725 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Incidence | 3 | 2018 | 25622 | 0.08 | Why? |
| Respiratory Protective Devices | 1 | 2017 | 1637 | 0.07 | Why? |
| Pregnant Women | 1 | 2019 | 2535 | 0.07 | Why? |
| Models, Statistical | 2 | 2020 | 5312 | 0.07 | Why? |
| Fear | 1 | 2020 | 3607 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.07 | Why? |
| Cross-Sectional Studies | 4 | 2020 | 53120 | 0.07 | Why? |
| Parents | 1 | 2017 | 2758 | 0.06 | Why? |
| Age Distribution | 1 | 2013 | 3567 | 0.06 | Why? |
| Adolescent | 4 | 2018 | 86841 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Recurrence | 1 | 2013 | 3675 | 0.06 | Why? |
| Vaccination | 2 | 2020 | 19050 | 0.06 | Why? |
| Health Policy | 2 | 2020 | 6242 | 0.06 | Why? |
| Pediatrics | 1 | 2018 | 2969 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Female | 9 | 2020 | 380317 | 0.05 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.05 | Why? |
| Child | 4 | 2019 | 70012 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.05 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Asia, Southeastern | 1 | 2020 | 390 | 0.05 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.04 | Why? |
| Quarantine | 2 | 2020 | 18418 | 0.04 | Why? |
| Surveys and Questionnaires | 3 | 2019 | 43792 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2017 | 12361 | 0.03 | Why? |
| Cohort Studies | 2 | 2017 | 36005 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2019 | 11559 | 0.03 | Why? |
| Hospitals, Public | 1 | 2019 | 774 | 0.03 | Why? |
| United Kingdom | 1 | 2013 | 18046 | 0.03 | Why? |
| Informed Consent | 1 | 2020 | 890 | 0.03 | Why? |
| Young Adult | 4 | 2019 | 93724 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Infection Control | 1 | 2017 | 23131 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Workplace | 1 | 2020 | 2075 | 0.02 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.02 | Why? |
| Perception | 1 | 2017 | 2827 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| England | 1 | 2017 | 5116 | 0.02 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 8811 | 0.02 | Why? |
| Computer Simulation | 1 | 2020 | 4982 | 0.02 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.02 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.02 | Why? |
| Schools | 1 | 2020 | 4187 | 0.02 | Why? |
| Risk Factors | 1 | 2013 | 71621 | 0.02 | Why? |
| Aged | 3 | 2018 | 215776 | 0.02 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| India | 1 | 2019 | 11875 | 0.01 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.01 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |